A Review of Mesenchymal Regenerative Medicine in the Treatment of Osteoarthritis
With nearly 30 million people in the US affected by stem cell therapy for osteoarthritis (OA), the condition continues to be among the leading causes of regenerative medicine for chronic pain and disability. Considering that advances in medical technology have increased overall life expectancy, the number of people living longer and dealing with the effects…